BioCentury

8:00 AM GMT, Feb 7, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Regulatory

Actemra regulatory update

Roche disclosed in its 4Q10 earnings that last year it submitted regulatory applications in the U.S. and EU to expand the label of tocilizumab to include the treatment of systemic juvenile idiopathic arthritis. The humanized mAb against

Read the full 375 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.